Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
|Live BSE Quotes||Sep 23, 2016 (Close)|
|Price (Rs)38.25||Open (Rs) 38.80||High (Rs) 39.00||Low (Rs) 38.15|
|% Change-1.03||Volume 84,665||Value (Rs) 3,271,537||52-Week H/L 67.50 / 32.60|
|Live NSE Quotes||Sep 23, 2016 3:29:57 PM|
|Price (Rs)38.05||Open (Rs) 38.75||High (Rs) 39.00||Low (Rs) 38.00|
|% Change-1.42||Volume 199,317||Value (Rs) 7,675,698||52-Week H/L 75.55 / 42.50|
|EPS (Rs)* -35.98||P/E Ratio (x) NM||Market Cap (Rs m) 3,261.20||P/BV (x) 0.86|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|ORCHID CHEMICALS Stock Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.
Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.
Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.
Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.
Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.More Views on News
The finance minister at a recent conference got nostalgic about the Vajpayee era when rents were fairly close to EMIs.
Strong faith of foreign promoters in the Indian economy cements our long-term view on the Sensex.
Voltas and Tata Communications top performers under Cyrus Mistry.
Apurva Sheth talks about the sixth primary data point in futures and options market - Open Interest.
PersonalFN explains why instead of focusing merely on how much your fund manager earns, a holistic assessment is imperative to select mutual funds prudently for your investment portfolio.More